SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Morgan Stanley cuts Genmab target price to $56 from $57

Valid market news retained in the public archive without immediate LiveCast distribution.

GMAB

Related stories